iAnthus Capital Holdings Inc

PINK:ITHUF USA Drug Manufacturers - Specialty & Generic
Market Cap
$44.31 Million
Market Cap Rank
#29442 Global
#9757 in USA
Share Price
$0.01
Change (1 day)
-7.14%
52-Week Range
$0.01 - $0.01
All Time High
$6.95
About

iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. The company also develops, produces, and distributors of branded cannabis products under the MPX, Anthologie, Black Label, Cheetah, Frutful, Last Resort, Moodz, Sunshine State, and The Vault brand names. It offers cannabis flower and trims, such as packaged f… Read more

iAnthus Capital Holdings Inc (ITHUF) - Net Assets

Latest net assets as of September 2025: $-89.60 Million USD

Based on the latest financial reports, iAnthus Capital Holdings Inc (ITHUF) has net assets worth $-89.60 Million USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($255.95 Million) and total liabilities ($345.55 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-89.60 Million
% of Total Assets -35.01%
Annual Growth Rate N/A
5-Year Change -228.91%
10-Year Change -15904.18%
Growth Volatility 1488.37

iAnthus Capital Holdings Inc - Net Assets Trend (2014–2024)

This chart illustrates how iAnthus Capital Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for iAnthus Capital Holdings Inc (2014–2024)

The table below shows the annual net assets of iAnthus Capital Holdings Inc from 2014 to 2024.

Year Net Assets Change
2024-12-31 $-65.54 Million -6.29%
2023-12-31 $-61.67 Million -661.16%
2022-12-31 $10.99 Million +149.06%
2021-12-31 $-22.40 Million -144.05%
2020-12-31 $50.84 Million -86.11%
2019-12-31 $366.00 Million +228.97%
2018-12-31 $111.26 Million +409.76%
2017-12-31 $21.83 Million +24.67%
2016-12-31 $17.51 Million +4121.43%
2015-12-31 $414.71K +188.47%
2014-12-31 $-468.77K --

Equity Component Analysis

This analysis shows how different components contribute to iAnthus Capital Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 133488876200.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components $1.27 Billion %
Total Equity $-65.54 Million 100.00%

iAnthus Capital Holdings Inc Competitors by Market Cap

The table below lists competitors of iAnthus Capital Holdings Inc ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in iAnthus Capital Holdings Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from -61,666,000 to -65,542,000, a change of -3,876,000.
  • Net loss of 7,636,000 reduced equity.
  • Share repurchases of 283,000 reduced equity.
  • Other factors increased equity by 4,043,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-7.64 Million -11.65%
Share Repurchases $283.00K -0.43%
Other Changes $4.04 Million +6.17%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares iAnthus Capital Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2014-12-31 $-0.05 $0.01 x
2015-12-31 $0.02 $0.01 x
2016-12-31 $1.10 $0.01 x
2017-12-31 $0.76 $0.01 x
2018-12-31 $1.74 $0.01 x
2019-12-31 $2.31 $0.01 x
2020-12-31 $0.30 $0.01 x
2021-12-31 $-0.13 $0.01 x
2022-12-31 $0.00 $0.01 x
2023-12-31 $-0.01 $0.01 x
2024-12-31 $-0.01 $0.01 x

Capital Efficiency Dashboard

This dashboard shows how efficiently iAnthus Capital Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -4.56%
  • • Asset Turnover: 0.62x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-477.71%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2014 0.00% 0.00% 0.00x 0.00x $-1.52 Million
2015 -317.27% -2887.57% 0.05x 2.07x $-1.36 Million
2016 -28.88% -1290.87% 0.02x 1.14x $-6.81 Million
2017 -62.85% -569.81% 0.05x 2.10x $-15.90 Million
2018 -64.24% -2098.96% 0.02x 1.51x $-82.60 Million
2019 -82.31% -384.34% 0.13x 1.65x $-337.85 Million
2020 -609.79% -204.41% 0.42x 7.04x $-315.12 Million
2021 0.00% -37.56% 0.59x 0.00x $-74.01 Million
2022 -4089.46% -275.34% 0.54x 27.62x $-450.49 Million
2023 0.00% -48.12% 0.57x 0.00x $-70.45 Million
2024 0.00% -4.56% 0.62x 0.00x $-1.08 Million

Industry Comparison

This section compares iAnthus Capital Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
iAnthus Capital Holdings Inc (ITHUF) $-89.60 Million 0.00% N/A $8.12 Million
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million